Background: Despite major advances, the treatment of sepsis is still a challenging problem for surgeons. This study was aimed to compare the therapeutic effects of methylprednisolone and tri-iodothyronine replacement therapy during an early sepsis. Material and methods: Forty male Wistar albino rats weighing 300-340g were divided into the Control, CLP, CLP/MP, CLP/T3 and CLP/MP/T3 groups. The Control group underwent a sham operation. Only cecal ligation and puncture was performed in the CLP group. The CLP/MP groups received an intramuscular injection of (MP) methylprednisolone (30 mg/kg) at one and half hour before CLP. The CLP/T3 group was given an intraperitoneal (IP) injection of tyroid hormone (T3) 0.4 μg/100 g immediately after CLP. The CLP/MP/T3 group was given IM injection of MP 30 mg/kg before CLP and IP injection of T3 0.4 μg/100 g after CLP. Hemavet changes, blood cultures, peritoneal bacteria content, hormonal alterations and histopathologic changes of intestinal, lung and liver tissue were used to asses the possible therapeutic effects of MP and T3 during early sepsis. Results: A septic insult resulted in signifi cant alterations on hemavet values, free T3, free T4 and cortisol levels, peritoneal bacteria content and intestinal lung and liver tissue samples of the CLP group. Hemavet changes and peritoneal infl ammation fi ndings were signifi cantly limited in the CLP/T3 and CLP/MP/T3 groups. Histopathologic changes had no signifi cant difference between the groups during an early sepsis. Conclusion: Compared to the MP replacement therapy, therapeutic effects of T3 replacement therapy have been found signifi cantly more promising (Tab. 1, Fig. 10, Ref. 49 Despite advances in systemic antibiotics and aggressive surgical intervention, septic shock and multiorgan failure resulting from sepsis continue to be the most common cause of death in surgical intensive care units. Over the past 20 years a large number of clinical trials in septic patients have been performed. In these trials, a variety of therapeutic agents for sepsis have been evaluated, based largely on progress in the understanding of the pathophysiology of sepsis (1-3).The use of corticosteroids has undergone a re-evaluation after the recognition of the adrenal insuffi ciency in septic patients. Recent reports in literature suggest that the treatment of specifi c populations of septic patients with corticosteroid supplementation provide a survival advantage in critically ill patients (4-7).There is also a vast literature on the changes in thyroid function tests that occur during non-thyroidal illness such as sepsis. The changes are defi ned as a decreased concentration of plasma tri-iodotyronine with normal or low thyroxine. Therapy with thyroid hormone as either thyroxine or tri-iodothyronine has been suggested for patients with sepsis, cardiac disease, pulmonary disease or severe infection (8)(9)(10)(11)(12).This study aimed to evaluation and comparison of the effects of methylprednisolone and tri-iodthyronine replacement therapy d...